**Hims & Hers Withdraws Weight-Loss Drug Following FDA Investigation**
Hims & Hers has decided to discontinue its weight-loss medication after the U.S. Food and Drug Administration (FDA) began probing the product. The drug was alleged to infringe on Novo Nordisk’s patent for Wegovy, a popular obesity treatment. Novo Nordisk had raised concerns that the telehealth company’s medication was a …